NJ AJR 161
in committeeEstablishes New Jersey Pancreatic Cancer Commission.
New Jersey · 222 · lower
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did NJ AJR 161 pass?
Not yet. NJ AJR 161 is in committee and has not come to a final vote. Latest recorded action (2026-03-16): Introduced, Referred to Assembly Health Committee
What is NJ AJR 161 about?
NJ AJR 161 is a joint resolution in the 222 titled “Establishes New Jersey Pancreatic Cancer Commission.”.
Who sponsors NJ AJR 161?
Speight, Shanique, Donlon, Margie, M.D. are the primary sponsors of NJ AJR 161, joined by 1 cosponsor.
- Introduced
- 2026-03-16
- Latest action
- 2026-03-16 — Introduced, Referred to Assembly Health Committee
- Bill type
- joint resolution
- Last updated
- —
Sponsors
- Speight, Shaniqueprimary
- Donlon, Margie, M.D.primary
- Scharfenberger, Gerrycosponsor
Committees
Not provided by source.
Action timeline
Newest first
2026-03-16
Introduced, Referred to Assembly Health Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-09-13T06:34:57.164819Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=AJR 161. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.